Long-term clinical and economic outcomes associated with angiotensin II receptor blocker use in hypertensive patients

Author： Swindle Jason P.   Buzinec Paul   Iorga ŞŞerban R.   Ramaswamy Krishnan   Panjabi Sumeet  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.9, 2011-09, pp. : 1719-1731

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 722-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Angiotensin II Type 1 Receptor Blocker on Blood Pressure Variability and Cardiovascular Remodeling in Hypertensive Patients on Chronic Peritoneal Dialysis

By  

Nephron Clin Pract, Vol. 112, Iss. 1, 2009-04 ,pp. : c31-c40

Karger

Access to resources Recommend Favorite

Risk of hyperkalemia and combined use of spironolactone and long‐term ACE inhibitor/angiotensin receptor blocker therapy in heart failure using real‐life data: a population‐ and insurance‐based cohort

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 4, 2015-04 ,pp. : 406-413

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Statin Therapy on Clinical Outcomes in Chronic Heart Failure Patients According to Beta-Blocker Use: Results of CIBIS II

By  

Cardiology, Vol. 108, Iss. 1, 2006-09 ,pp. : 28-34

Karger

Access to resources Recommend Favorite

Effect of angiotensin II receptor blocker, olmesartan, on turnover of bone metabolism in bedridden elderly hypertensive women with disuse syndrome

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 8, 2015-08 ,pp. : 1064-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite